by Karen O'Hanlon Cohrt | Nov 27, 2017 | Industry News, Trends
In our last post, we walked through some of the canonical hypotheses surrounding Alzheimer’s Disease (AD), but what about all the other hypotheses that are knocking around? Since AD’s discovery over a century ago countless ideas have emerged, yet the exact cause of...
by Karen O'Hanlon Cohrt | Jul 13, 2025 | Cell Culture Techniques, Disease Models
In our last article, we compared 2D organ-on-a-chip devices and 3D organoids with respect to their use in drug discovery, highlighting their importance in modeling diseases and evaluating efficacy and safety during drug discovery and development . We also presented...
by Karen O'Hanlon Cohrt | Apr 9, 2025 | Disease Models
In a previous Cell of The Month article, we explored the biology of the kidney. We highlighted the structure and function of the glomerulus podocytes and proximal tubules; these are specialized cell types found in the nephron, which is the kidney’s key structural and...
by Karen O'Hanlon Cohrt | Sep 24, 2024 | Citation Alerts
Tempo-iOligo™was cited in Nature in a major infectious disease study that offers the first explanation as to why herpes simplex virus 1 (HSV-1) infection in the brain is very rare, despite the fact that most of us have been infected with the virus. The study used...
by Karen O'Hanlon Cohrt | Jul 24, 2024 | Trends
In our last article, we introduced mast cells, their origins and morphology, and summarized how they are activated during IgE-mediated allergic responses. Here, we shift gears and explore how mast cells, together with microglia and the blood brain barrier, contribute...
